Chest Wall Resection for Recurrent Breast Cancer

Study Description

Breast cancers invading the chest wall are a difficult clinical problem, and little evidence exists to guide treatment decisions. Surgical resection can be a useful part of treatment for both curative and palliative purposes in select patients. We are carrying out a prospective trial to evaluate how surgery influences quality of life, and to measure locoregional recurrence, overall survival and morbidity in patients with recurrent breast cancer in the chest wall. Patients with primary tumors that invade the chest wall who fail chemotherapy and radiation therapy are also eligible.

Visual Protocol

Study Locations

Toronto General Hospital/Princess Maragaret Cancer Center/University Health Network

Contact Information

Jen Lister (Clinical Trial Coordinator) at (416) 340-4857 or (647) 678-9549 for referral information.

Other Links:

Clinical Trials.Gov Registration: